Blood Coagulation Disorder clinical trials at UCSD

1 in progress, 0 open to eligible people

Showing trials for

  • Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)

    Sorry, accepting new patients by invitation only

    The BMN 270 clinical development program consists of multiple interventional studies designed to assess the safety and efficacy of a single infusion of BMN 270 for at least 5 years post-infusion. This long-term follow-up study is needed to help further understand the long-term safety of BMN 270 beyond 5 years and to assess the durability of efficacy.

    San Diego, California and other locations

Last updated: